Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.
Ewing sarcoma is the second most common bone malignancy in children and young adults. It is driven by oncogenic fusion proteins (i.e. EWS/FLI1) acting as aberrant transcription factors that upregulate and downregulate target genes, leading to cellular transformation. Thus, identificating these targe...
Main Authors: | Noelia Agra, Florencia Cidre, Laura García-García, Juan de la Parra, Javier Alonso |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23750284/pdf/?tool=EBI |
Similar Items
-
EWS/FLI1 target genes and therapeutic opportunities in Ewing sarcoma
by: Florencia eCidre, et al.
Published: (2015-07-01) -
Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma
by: David Herrero-Martin, et al.
Published: (2011-01-01) -
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
by: Maria E. Gierisch, et al.
Published: (2019-01-01) -
Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
by: Patrick J. Grohar, et al.
Published: (2011-02-01) -
Characterization of length-dependent GGAA-microsatellites in EWS/FLI mediated Ewing sarcoma oncogenesis
by: Johnson, Kirsten M.
Published: (2018)